SLC12A2 and fragile X syndrome: In multiple FXS and ASD animal models the Nkcc1 inhibitor bumetanide rescues GABAergic neurotransmission as well as social and repetitive behaviors (Tyzio et al., 2014; Amin et al., 2017; Zeidler et al., 2017; Savardi et al., 2020).